Five-year POLARIX analysis confirms positive impact of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone Meeting Abstract
| Authors: | Collins, G.; Salles, G.; Morschhauser, F.; Sehn, L. H.; Herrera, A. F.; Friedberg, J. W.; Trněný, M.; Lenz, G.; Sharman, J. P.; Herbaux, C.; Burke, J. M.; Matasar, M.; Song, Y.; Pinto, A.; Rai, S.; Izutsu, K.; Chohan, S.; Sugidono, M.; Jiang, Y.; Batlevi, C. L.; Yan, M.; Tilly, H.; Flowers, C. R. |
| Abstract Title: | Five-year POLARIX analysis confirms positive impact of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone |
| Meeting Title: | 65th Annual Scientific Meeting of the British Society for Haematology (BSH) |
| Journal Title: | British Journal of Haematology |
| Volume: | 206 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2025 Apr 27-29 |
| Meeting Location: | Glasgow, Scotland |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2025-04-01 |
| Language: | English |
| ACCESSION: | WOS:001517858300123 |
| PROVIDER: | wos |
| DOI: | 10.1111/bjh.20117 |
| Notes: | Meeting Abstract: PO77 -- Source: Wos |
